Efficacy and Safety of Zongertinib in Previously Treated and Treatment-Naïve HER2-Mutant NSCLC from Beamion LUNG-1 Trial | AJMC
Efficacy and Safety of Zongertinib in Previously Treated and Treatment …
1 month ago
ajmc.com
Dr Halmos on the FDA Approval of Zongertinib in HER2 TKD–Mutated NSCLC | OncLive
Dr Halmos on the FDA Approval of Zongertinib in HER2 TKD–Mutate…
1 week ago
onclive.com
Beamion LUNG-1: Zongertinib in Advanced HER2-Mutated NSCLC | OncLive
5:59
Beamion LUNG-1: Zongertinib in Advanced HER2-Mutated NSCLC | …
1 week ago
onclive.com
FDA Approval of Hernexeos (zongertinib) for Patients with HER2-Mutant Advanced NSCLC | Dr. Umesh Laddi
FDA Approval of Hernexeos (zongertinib) for Patients with HER…
718 views2 months ago
linkedin.com
Dr Sabari on the Activity of Zongertinib in Pretreated, Advanced, HER2-Mutated NSCLC | OncLive
2:45
Dr Sabari on the Activity of Zongertinib in Pretreated, Advanc…
9 months ago
onclive.com
Zongertinib 71% ORR for HER2-Mutant NSCLC: Key Insights from AACR 2025
1:37
Zongertinib 71% ORR for HER2-Mutant NSCLC: Key Insights from …
10 months ago
oncologytube.com
Beamion Lung 1: Zongertinib (BI 1810631) in Advanced HER2 NSCLC | OncLive
Beamion Lung 1: Zongertinib (BI 1810631) in Advanced HER2 NSCL…
Jan 12, 2024
onclive.com
Evaluating Zongertinib After ADC Therapy: Efficacy, Safety, and ILD …
2 months ago
onclive.com
Boehringer's zongertinib shows encouraging efficacy and tolerabil…
Sep 9, 2024
financialpost.com
Boehringer's zongertinib receives Priority Review from U.S. FDA for …
Feb 19, 2025
financialpost.com
Dr Baik on the Clinical Utility of Zongertinib in Previously Treated …
Nov 6, 2024
onclive.com
Boehringer’s zongertinib receives Priority Review from U.S. FDA for …
Feb 19, 2025
thespec.com
Beamion LUNG-1: Examining the Efficacy and Safety of Zongertinib …
5 months ago
onclive.com
FDA Grants Accelerated Approval to Zongertinib for Unresectable or M…
1 week ago
onclive.com
2:17
Dr Heymach on the Efficacy of Zongertinib in Previously Treated …
10 months ago
onclive.com
FDA Greenlights Zongertinib for Patients with HER2-Mutated Non-…
7 months ago
archyde.com
0:31
Hernexeos (zongertinib) receives accelerated FDA approval for prev…
1.2K views6 months ago
FacebookXtalks Webinars
Emerging Oral HER2-Targeted TKIs (Zongertinib and Sevabertinib): Eff…
9 months ago
onclive.com
Overview of Targeted Therapy Updates in NSCLC (Zongertinib, T…
6 months ago
vumedi.com
0:32
John V. Heymach, MD, PhD, of MD Anderson Cancer Center discusse…
90 views10 months ago
FacebookOncLive
0:44
The Royal Marsden NHS Foundation Trust | A trial testing the use of th…
19.6K views4 months ago
Instagramroyalmarsdennhs
1:06
New FDA Approval | Hernexeos (zongertinib) for HER2-Mutated No…
82 views1 week ago
YouTubeGO2 for Lung Cancer
AACR: HER2 targeted therapy shows promise in previously treat…
10 months ago
newswise.com
1:56
Hernexeos (Zongertinib) – Benefits, FDA Approval, Effectiveness & Sa…
175 views7 months ago
YouTubeReality Reviews
0:09
Zongertinib Data in HER2-Mutant Advanced NSCLC: Key Findings E…
132 views10 months ago
YouTubeMCQ Pedia
2:00
Beamion LUNG-1: first-line zongertinib in advanced HER2-mu…
132 views3 months ago
YouTubeVJOncology
4:11
Highlights: The HER2 diagnostic and treatment landscape in NSCLC
75 views10 months ago
YouTubeCOR2ED The Heart of Medical Education
1:12
FDA Approval of Zongertinib for HER2 Mutated Non-Small Cell Lun…
547 views6 months ago
YouTubeOncBrothers: Practice-Changing Cancer Discus…
0:57
PROs in the Beamion LUNG-1 of zongertinib in HER2-mutated NSCLC
154 views8 months ago
YouTubeVJOncology
0:45
A Game Changer 🚨 The recent approval of Zongertinib marks the …
509 views5 months ago
FacebookMedscape
See more videos
Static thumbnail place holder